| Nawar Soda, MD | |
|
234 Brenwood St, Berea, KY 40403-1637 | |
| (859) 985-0302 | |
| Not Available |
| Full Name | Nawar Soda |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 234 Brenwood St, Berea, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083812598 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 41992 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Berea | Berea, KY | Hospital |
| Baptist Health Richmond | Richmond, KY | Hospital |
| The James B. Haggin Memorial Hospital | Harrodsburg, KY | Hospital |
| Entity Name | Berea Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912054792 PECOS PAC ID: 2567485949 Enrollment ID: O20060111001073 |
News Archive
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
› Verified 8 days ago
| Entity Name | Georgetown Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780838847 PECOS PAC ID: 6608938287 Enrollment ID: O20081216000010 |
News Archive
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
› Verified 8 days ago
| Entity Name | Medical Laser Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649401563 PECOS PAC ID: 9830238823 Enrollment ID: O20091204000183 |
News Archive
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
› Verified 8 days ago
| Entity Name | Lexington Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225374887 PECOS PAC ID: 9830344688 Enrollment ID: O20130227000342 |
News Archive
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
› Verified 8 days ago
| Entity Name | Man O War Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083101240 PECOS PAC ID: 6002171386 Enrollment ID: O20180607003185 |
News Archive
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nawar Soda, MD 2405 Rossini Pl, Lexington, KY 40509-4533 Ph: (859) 466-8956 | Nawar Soda, MD 234 Brenwood St, Berea, KY 40403-1637 Ph: (859) 985-0302 |
News Archive
Pittsburgh is treating diabetes more cost effectively than the rest of the state and nation, and its efforts to help people better manage their disease are paying dividends. Still, a gap exists between the region and the nation's top performers, according to the third annual Pittsburgh Business Group on Health Type 2 Diabetes Report.
Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration cleared the Cochlear Baha 4 Attract System for use in the United States. Cochlear is the only company to now offer patients a choice of either a magnetic or a direct bone conduction hearing solution.
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.
A new neurobiological study has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
› Verified 8 days ago
Jessica Abney Pennington, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2750 Battlefield Memorial Hwy, Berea, KY 40403 Phone: 859-986-0302 Fax: 859-986-0315 | |
Dr. Mary Margaret Miller, M.D., Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 Clay Dr, Berea, KY 40403 Phone: 859-985-8426 Fax: 859-985-8747 | |
Vicki Lou Hackman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Estill St, Berea, KY 40403 Phone: 859-985-1415 Fax: 859-986-6752 | |
Dr. Maureen A. Flannery, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 122 Main St, Berea, KY 40403 Phone: 859-986-0098 Fax: 419-710-9838 | |
Sarah E Helphinstine, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Legacy Dr, Berea, KY 40403 Phone: 859-986-2323 Fax: 606-436-0848 | |
Leigh A Delair, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2200 Menelaus Rd, Berea, KY 40403 Phone: 877-423-1330 Fax: 859-228-1567 |